miércoles, 13 de mayo de 2026

Early-Onset Colorectal Cancer Risk Factors Identified in Two Studies Damian McNamara, MA May 13, 2026 ++ ++ + + +

Early-Onset Colorectal Cancer Risk Factors Identified in Two Studies Damian McNamara, MA https://www.medscape.com/viewarticle/early-onset-colorectal-cancer-risk-factors-identified-two-2026a1000ffn May 13, 2026 https://www.medscape.com/c25/p14/digestive-disease-week-ddw-2026-2026a1000c5k Did Hyperglycemia Affect Inavolisib-Efficacy in Patients With Breast Cancer? Megan Brooks https://www.medscape.com/viewarticle/did-hyperglycemia-affect-inavolisib-efficacy-patients-breast-2026a1000fgf May 13, 2026 Efficacy outcomes were numerically higher among patients who experienced inavolisib-associated hyperglycemia, in a post hoc exploratory analysis of the INAVO120 trial. That trial found that patients with PIK3CA-mutated, hormone receptor (HR)-positive, HER2-negative advanced breast cancer benefitted from the addition of inavolisib to standard palbociclib and fulvestrant. https://www.medscape.com/c25/p14/esmo-breast-cancer-2026-2026a1000c6q Obesity Drugs Linked to Lower Cancer Risk Edited by Archita Rai https://www.medscape.com/viewarticle/obesity-drugs-linked-lower-cancer-risk-2026a1000fgc May 13, 2026 Only 1 in 4 Eligible Adults Receive Lung Screening Kelsey Mesmer https://www.medscape.com/viewarticle/only-1-4-eligible-adults-receive-lung-screening-2026a1000fee May 13, 2026 Low PSA Alone May Not Fully Predict Survival in Advanced Prostate Cancer Edited by Victoria Stern https://www.medscape.com/viewarticle/low-psa-alone-may-not-fully-predict-survival-advanced-2026a1000few May 13, 2026

No hay comentarios:

Publicar un comentario